iShares Neuroscience and Healthcare ETF
IBRN
3 hedge funds and large institutions have $3.8M invested in iShares Neuroscience and Healthcare ETF in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
1.53% more ownership
Funds ownership: 88.91% → 90.45% (+1.5%)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
12% less capital invested
Capital invested by funds: $4.32M → $3.8M (-$524K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$364K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$293K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$24 |
IBRN Hedge Fund Activity: Q3 2023 in Review
3 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q3 2023, worth a combined $3.8M — down 12% from $4.32M a quarter earlier.
Fund positioning in IBRN was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $364K. The largest seller was Flow Traders U.S., cutting an estimated $293K.
- 3 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $3.8M of iShares Neuroscience and Healthcare ETF stock for Q3 2023, down 12% quarter-over-quarter.
- 1 fund opened new iShares Neuroscience and Healthcare ETF positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q3 2023 was Jane Street, an estimated $364K added.
- The largest iShares Neuroscience and Healthcare ETF seller in Q3 2023 was Flow Traders U.S., an estimated $293K sold.
Based on aggregated 13F filings for Q3 2023.